Home » All » Stock Forecast » Immunome Inc. Common Stock Forecast

Immunome Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -1.65%Market Cap $2.70B · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$23.62 ▼ -0.97%	Yesterday	$23.95 ▲ +0.41%	Tomorrow's Immunome Inc. Common Stock (IMNM) setup is anchored to $23.85 and targets $23.62 (-0.97%). The near-term read is downside; watch $24.57 / $23.13 because daily realized volatility is about 5.01%.
Tomorrow's Immunome Inc. Common Stock (IMNM) setup is anchored to $23.85 and targets $23.62 (-0.97%). The near-term read is downside; watch $24.57 / $23.13 because daily realized volatility is about 5.01%.
Week	$23.13 ▼ -3.02%	Last Week	$24.15 ▲ +1.27%	The 7-day Immunome Inc. Common Stock model moves from $24.15 to $23.13 (-3.02%). It gives downside momentum context for this stock, so breaks around $24.57 / $23.13 matter more than a single tick.
The 7-day Immunome Inc. Common Stock model moves from $24.15 to $23.13 (-3.02%). It gives downside momentum context for this stock, so breaks around $24.57 / $23.13 matter more than a single tick.
Month	$22.31 ▼ -6.44%	Last Month	$24.50 ▲ +2.71%	The 1-month Immunome Inc. Common Stock target is $22.31 (-6.44%), compared with the live reference near $23.85. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Immunome Inc. Common Stock target is $22.31 (-6.44%), compared with the live reference near $23.85. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$21.09 ▼ -11.57%	Last Year	$25.01 ▲ +4.86%	The 1-year Immunome Inc. Common Stock scenario points to $21.09 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Immunome Inc. Common Stock scenario points to $21.09 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$18.23 ▼ -23.57%	5 Years Ago	$26.21 ▲ +9.90%	The 5-year Immunome Inc. Common Stock view is $18.23 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Immunome Inc. Common Stock view is $18.23 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$23.62▼ -0.97%

Yesterday$23.95▲ +0.41%

Tomorrow's Immunome Inc. Common Stock (IMNM) setup is anchored to $23.85 and targets $23.62 (-0.97%). The near-term read is downside; watch $24.57 / $23.13 because daily realized volatility is about 5.01%.

Week$23.13▼ -3.02%

Last Week$24.15▲ +1.27%

The 7-day Immunome Inc. Common Stock model moves from $24.15 to $23.13 (-3.02%). It gives downside momentum context for this stock, so breaks around $24.57 / $23.13 matter more than a single tick.

Month$22.31▼ -6.44%

Last Month$24.50▲ +2.71%

The 1-month Immunome Inc. Common Stock target is $22.31 (-6.44%), compared with the live reference near $23.85. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$21.09▼ -11.57%

Last Year$25.01▲ +4.86%

The 1-year Immunome Inc. Common Stock scenario points to $21.09 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$18.23▼ -23.57%

5 Years Ago$26.21▲ +9.90%

The 5-year Immunome Inc. Common Stock view is $18.23 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$23.85	Mid
Daily Change	-1.65%	Below
Volatility Cap	20.0%	Mid
Confidence	61%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$23.85

Daily Change-1.65%

Market Cap$2.70B

Sourcenasdaq-screener

Current	$23.85	Daily Change	-1.65%
Market Cap	$2.70B	Source	nasdaq-screener

Support & Resistance Levels

$23.13Support 1

$23.85Current

$24.57Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$23.85Live reference price

Used as the anchor for generated forecast calculations.

Next Month$22.31Model projection-6.44%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

61%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

61%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in IMNM today

Bullish Scenario

$25.04

+5.00% from current

Target Price$25.04

ScenarioUpside momentum

Probability53%

Base Scenario

$22.31

-6.44%

Target Price$22.31

ScenarioCapped drift

Probability61%

Bearish Scenario

$22.66

-5.00% from current

Target Price$22.66

ScenarioVolatility drawdown

Probability39%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 36/100

24H drift-0.97%

7D drift-3.02%

30D drift-6.44%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 29/100

1M outlook-6.44%

1Y outlook-11.57%

5Y outlook-23.57%

Frequently Asked Questions

Q What is the Immunome Inc. Common Stock (IMNM) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Immunome Inc. Common Stock is projected near $23.62 versus the current reference around $23.85. That implies a modeled move of -0.97% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for IMNM?

The weekly Immunome Inc. Common Stock model points to $23.13, which maps to an expected drift of -3.02% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Immunome Inc. Common Stock 1-month and 1-year targets?

The Immunome Inc. Common Stock 1-month target is $22.31 (-6.44%), while the 1-year target is $21.09 (-11.57%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Immunome Inc. Common Stock 5-year scenario differ from short-term rows?

The Immunome Inc. Common Stock long-horizon scenario sits near $18.23 with a modeled change of -23.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are IMNM support and resistance zones right now?

For Immunome Inc. Common Stock, nearest resistance is around $23.13, while nearest support is around $24.57. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Immunome Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.